Right now, a global movement to eliminate cervical cancer is being driven by the energy, passion and momentum of communities, organizations and individuals working towards catalyzing change.
A brief look at the epidemiology of cervical cancer shows that Cervical cancer is the third most common malignancy in women worldwide. The frequency of it does vary considerably between developed and developing countries, however:
- It is the second most common cause of cancer-related deaths in women in developing countries, with rates on the rise
- However, not even among the top ten common causes in developed countries
Long-lasting infection with certain types of human papillomavirus (HPV) is the main cause of cervical cancer. Screening tests and the HPV vaccine can help prevent cervical cancer. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life. In the United States, cervical cancer is relatively uncommon. The incidence of invasive cervical cancer has declined steadily in the US over the past few decades (since 2004, rates have decreased by 2.1% per year in women younger than 50 years and by 3.1% per year in women 50 years of age and older). This trend has been attributed to mass screenings with Pap tests. Regular cervical screening appointments can prevent up to 75% of instances of cervical cancer, saving 5000 lives per year in the UK alone.
A Global Movement to Eliminate Cervical Cancer
A “call to action” was made by the World Health Organization (WHO) in May of 2018 to eliminate cervical cancer worldwide. This a laudable goal, and one that many organizations across the globe have endorsed. WHO’s Director-General, Dr. Tedros stated that, “The world already has the necessary tools; they just need to be made accessible. “
By the year 2030, all countries can achieve 90% HPV vaccination coverage, 70% screening coverage, and 90% access to treatment for cervical pre-cancer and cancer, including access to palliative care. – WHO
Similarly, and despite the immense impact of COVID-19, in August of 2020 the World Health Assembly passed a resolution calling for elimination and adoption of a strategy to end Cervical cancer.
The moment has arrived for an ambitious, inclusive strategy to accelerate eliminating cervical cancer as a public health problem. Elimination is within the reach of all countries. Both Aixial and Cmed are quite proud of our Sponsor partnerships and positive work on cancer trials. Together, we know we can help to eradicate cervical cancer for good.
